John E. Palardy
Impact in
- Immunology top 5%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
- Immunology 17
- Immune Response and Inflammation 16
-
- Sepsis Diagnosis and Treatment 4
- Pneumonia and Respiratory Infections 2
- Co-authors
- Steven M. Opal (29 shared papers)Nicolas A. Parejo (18 shared papers)John P. Pribble (2 shared papers)Patrick J. Scannon (1 shared paper)Jean‐Louis Vincent (1 shared paper)Mark White (1 shared paper)Jon H. Lemke (1 shared paper)Stephen F. Carroll (1 shared paper)
- Journals
- The Journal of Infectious Diseases (10 papers)Shock (5 papers)Critical Care Medicine (4 papers)Antimicrobial Agents and Chemotherapy (2 papers)Blood (2 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
John E. Palardy
30 papers receiving 1.4k citations
John E. Palardy's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 559
- Clinical Biochemistry 161
- Critical Care and Intensive Care Medicine 81
- Microbiology 80
- Epidemiology 396
Countries citing papers authored by John E. Palardy
This map shows the geographic impact of John E. Palardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Palardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Palardy more than expected).
Fields of papers citing papers by John E. Palardy
This network shows the impact of papers produced by John E. Palardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Palardy. The network helps show where John E. Palardy may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Palardy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock Hit paper breakdown → | 1999 | 517 |
| 2 | 2007 | 140 | |
| 3 | 1994 | 102 | |
| 4 | 2003 | 97 | |
| 5 | 2006 | 55 | |
| 6 | 2011 | 46 | |
| 7 | 2015 | 45 | |
| 8 | 2007 | 40 | |
| 9 | 2001 | 38 | |
| 10 | 2005 | 37 | |
| 11 | 2010 | 37 | |
| 12 | 1998 | 32 | |
| 13 | 2014 | 32 | |
| 14 | 2003 | 30 | |
| 15 | 1999 | 29 | |
| 16 | 2010 | 29 | |
| 17 | 2005 | 26 | |
| 18 | 2004 | 26 | |
| 19 | 2003 | 24 | |
| 20 | 2002 | 22 |
About John E. Palardy
John E. Palardy is a scholar working on Immunology, Epidemiology, Oncology, Molecular Biology and Microbiology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Response and Inflammation (16 papers), Neutropenia and Cancer Infections (5 papers), Sepsis Diagnosis and Treatment (4 papers), Bacillus and Francisella bacterial research (4 papers), Antimicrobial Peptides and Activities (3 papers), Bacterial Infections and Vaccines (2 papers), Pneumonia and Respiratory Infections (2 papers) and Advanced Glycation End Products research (2 papers). The work is most often cited by research in Immunology (559 citations), Clinical Biochemistry (161 citations), Critical Care and Intensive Care Medicine (81 citations), Microbiology (80 citations) and Epidemiology (396 citations). John E. Palardy has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Steven M. Opal, Nicolas A. Parejo, John P. Pribble, Patrick J. Scannon, Jean‐Louis Vincent, Mark White, Jon H. Lemke, Stephen F. Carroll, James C. Keith and Yow‐Pin Lim. Their work appears in journals such as The Journal of Infectious Diseases, Shock, Critical Care Medicine, Antimicrobial Agents and Chemotherapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.